The Targeted Approach: How Acute Myeloid Leukemia Treatment Is Evolving with Epigenetic Therapies
Acute myeloid leukemia (AML) is a fast-growing cancer of the blood and bone marrow that has historically been associated with a poor prognosis. The treatment landscape for AML has undergone a significant transformation, moving beyond traditional intensive chemotherapy to include a range of targeted therapies. Acute myeloid leukemia treatment now incorporates agents like decitabine, a...
0 Comments 0 Shares 266 Views 0 Reviews